
EURICAN® L4 - Boehringer Ingelheim
EURICAN ® L4 is the latest generation of dog vaccines against leptospirosis: Active immunisation of dogs from seven weeks of age to prevent or reduce mortality, clinical signs, infection, …
Boehringer Ingelheim launches EURICAN
The new, non-adjuvanted EURICAN® L4 vaccine provides effective immunity against four key Leptospira serogroups, including L. Australis, which has emerged due to changes in the …
百靈佳殷格翰推出EURICAN® L4疫苗,為犬隻提供對抗鉤端螺旋 …
2024年12月7日 · EURICAN® L4保護犬隻免受鉤端螺旋體病的威脅. EURICAN® L4是一種非佐劑型疫苗,針對四種主要血清群(包括L. Australis、L. Canicola、L. Icterohaemorrhagiae和L. …
Skin Care Products & Eczema Relief | Eucerin® Skincare
Ultra-lightweight and clinically proven to immediately soothe irritation from eczema. With High-Performance Face, Sun, & Body care. Intensively hydrates and visibly smoothes fine lines and …
Eurican L4 - European Medicines Agency (EMA)
This medicine is authorised for use in the European Union.
EURICANⓇ DAPPI-LR - Med'Vet
Immunisation active des chiens afin de : - prévenir la mortalité et les signes cliniques causés par le virus de la maladie de Carré (CDV), - prévenir la mortalité et les signes cliniques causés par …
EURICAN DHPPI2-LR LYOPHILISATE AND SUSPENSION FOR …
EURICAN DHPPI2-LR LYOPHILISATE AND SUSPENSION FOR SUSPENSION FOR INJECTION EURICAN DAPPi-LR Active substance: Rabies virus, strain G52, Inactivated. …
Clinical particulars - Eurican Lmulti Suspension for injection
When Eurican Lmulti is used alone, inject a 1-ml dose subcutaneously. When Eurican Lmulti is used as a diluent of a Boehringer Ingelheim freeze-dried vaccine against distemper, …
Eurican® DAPPi-Lmulti – Vetmedica
Eurican® DAPPi-Lmulti Lyophilisat und Suspension zur aktiven Immunisierung von Hunden gegen CDV, CAV, CAV-2, CPV, CPiV und Leptospira
Clinical particulars - Eurican DHPPi - NOAH Compendium
- prevent mortality and clinical signs caused by canine distemper virus (CDV), - prevent mortality and clinical signs caused by infectious canine hepatitis virus (CAV), - reduce viral excretion …